GeoVax Labs Granted Allowance By FDA To Start Phase 1 Clinical Trial For HIV/AIDS Therapeutic Vaccine

GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the FDA (US Food and Drug Administration) to begin a phase 1 clinical trial for GeoVax's therapeutic vaccine, which is intended as a treatment for individuals infected with HIV (Human Immunodeficiency Virus)...

Add to: del.icio.us | Digg